These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23977306)

  • 1. Assessing interactions between the association of common genetic variant at 1p11 (rs11249433) and hormone receptor status with breast cancer risk.
    Chen Q; Shi R; Liu W; Jiang D
    PLoS One; 2013; 8(8):e72487. PubMed ID: 23977306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between 1p11-rs11249433 polymorphism and breast cancer susceptibility: evidence from 15 case-control studies.
    Wu S; Cai J; Wang H; Zhang H; Yang W
    PLoS One; 2013; 8(8):e72526. PubMed ID: 23977314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium.
    Figueroa JD; Garcia-Closas M; Humphreys M; Platte R; Hopper JL; Southey MC; Apicella C; Hammet F; Schmidt MK; Broeks A; Tollenaar RA; Van't Veer LJ; Fasching PA; Beckmann MW; Ekici AB; Strick R; Peto J; dos Santos Silva I; Fletcher O; Johnson N; Sawyer E; Tomlinson I; Kerin M; Burwinkel B; Marme F; Schneeweiss A; Sohn C; Bojesen S; Flyger H; Nordestgaard BG; Benítez J; Milne RL; Ignacio Arias J; Zamora MP; Brenner H; Müller H; Arndt V; Rahman N; Turnbull C; Seal S; Renwick A; Brauch H; Justenhoven C; Brüning T; ; Chang-Claude J; Hein R; Wang-Gohrke S; Dörk T; Schürmann P; Bremer M; Hillemanns P; Nevanlinna H; Heikkinen T; Aittomäki K; Blomqvist C; Bogdanova N; Antonenkova N; Rogov YI; Karstens JH; Bermisheva M; Prokofieva D; Gantcev SH; Khusnutdinova E; Lindblom A; Margolin S; Chenevix-Trench G; Beesley J; Chen X; ; Mannermaa A; Kosma VM; Soini Y; Kataja V; Lambrechts D; Yesilyurt BT; Chrisiaens MR; Peeters S; Radice P; Peterlongo P; Manoukian S; Barile M; Couch F; Lee AM; Diasio R; Wang X; Giles GG; Severi G; Baglietto L; Maclean C; Offit K; Robson M; Joseph V; Gaudet M; John EM; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Andrulis I; Knight JA; Mulligan AM; O'Malley FP; Brinton LA; Sherman ME; Lissowska J; Chanock SJ; Hooning M; Martens JW; van den Ouweland AM; Collée JM; Hall P; Czene K; Cox A; Brock IW; Reed MW; Cross SS; Pharoah P; Dunning AM; Kang D; Yoo KY; Noh DY; Ahn SH; Jakubowska A; Lubinski J; Jaworska K; Durda K; Sangrajrang S; Gaborieau V; Brennan P; McKay J; Shen CY; Ding SL; Hsu HM; Yu JC; Anton-Culver H; Ziogas A; Ashworth A; Swerdlow A; Jones M; Orr N; Trentham-Dietz A; Egan K; Newcomb P; Titus-Ernstoff L; Easton D; Spurdle AB
    Hum Mol Genet; 2011 Dec; 20(23):4693-706. PubMed ID: 21852249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative assessment of 2q35-rs13387042 polymorphism and hormone receptor status with breast cancer risk.
    Gu C; Zhou L; Yu J
    PLoS One; 2013; 8(7):e66979. PubMed ID: 23894282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic variants at 1p11.2 and breast cancer risk: a two-stage study in Chinese women.
    Jiang Y; Shen H; Liu X; Dai J; Jin G; Qin Z; Chen J; Wang S; Wang X; Hu Z; Shen H
    PLoS One; 2011; 6(6):e21563. PubMed ID: 21738711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between 5p12 genomic markers and breast cancer susceptibility: evidence from 19 case-control studies.
    Wang X; Zhang L; Chen Z; Ma Y; Zhao Y; Rewuti A; Zhang F; Fu D; Han Y
    PLoS One; 2013; 8(9):e73611. PubMed ID: 24039999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing interactions between common genetic variant on 2q35 and hormone receptor status with breast cancer risk: evidence based on 26 studies.
    Huang T; Hong J; Lin W; Yang Q; Ni K; Wu Q; Sun J
    PLoS One; 2013; 8(8):e69056. PubMed ID: 23976942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NOTCH2 in breast cancer: association of SNP rs11249433 with gene expression in ER-positive breast tumors without TP53 mutations.
    Fu YP; Edvardsen H; Kaushiva A; Arhancet JP; Howe TM; Kohaar I; Porter-Gill P; Shah A; Landmark-Høyvik H; Fosså SD; Ambs S; Naume B; Børresen-Dale AL; Kristensen VN; Prokunina-Olsson L
    Mol Cancer; 2010 May; 9():113. PubMed ID: 20482849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus.
    Horne HN; Chung CC; Zhang H; Yu K; Prokunina-Olsson L; Michailidou K; Bolla MK; Wang Q; Dennis J; Hopper JL; Southey MC; Schmidt MK; Broeks A; Muir K; Lophatananon A; Fasching PA; Beckmann MW; Fletcher O; Johnson N; Sawyer EJ; Tomlinson I; Burwinkel B; Marme F; Guénel P; Truong T; Bojesen SE; Flyger H; Benitez J; González-Neira A; Anton-Culver H; Neuhausen SL; Brenner H; Arndt V; Meindl A; Schmutzler RK; Brauch H; Hamann U; Nevanlinna H; Khan S; Matsuo K; Iwata H; Dörk T; Bogdanova NV; Lindblom A; Margolin S; Mannermaa A; Kosma VM; Chenevix-Trench G; ; Wu AH; Ven den Berg D; Smeets A; Zhao H; Chang-Claude J; Rudolph A; Radice P; Barile M; Couch FJ; Vachon C; Giles GG; Milne RL; Haiman CA; Marchand LL; Goldberg MS; Teo SH; Taib NA; Kristensen V; Borresen-Dale AL; Zheng W; Shrubsole M; Winqvist R; Jukkola-Vuorinen A; Andrulis IL; Knight JA; Devilee P; Seynaeve C; García-Closas M; Czene K; Darabi H; Hollestelle A; Martens JW; Li J; Lu W; Shu XO; Cox A; Cross SS; Blot W; Cai Q; Shah M; Luccarini C; Baynes C; Harrington P; Kang D; Choi JY; Hartman M; Chia KS; Kabisch M; Torres D; Jakubowska A; Lubinski J; Sangrajrang S; Brennan P; Slager S; Yannoukakos D; Shen CY; Hou MF; Swerdlow A; Orr N; Simard J; Hall P; Pharoah PD; Easton DF; Chanock SJ; Dunning AM; Figueroa JD
    PLoS One; 2016; 11(8):e0160316. PubMed ID: 27556229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
    Wang H; Yang Z; Zhang H
    Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative assessment of the association between rs2046210 at 6q25.1 and breast cancer risk.
    Wu X; Xu QQ; Guo L; Yu CT; Xiong YY; Wei ZY; Huo R; Li ST; Shen L; Niu JM; Liu L; Lin Y; He L; Qin SY
    PLoS One; 2013; 8(6):e65206. PubMed ID: 23785413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between 8q24 (rs13281615 and rs6983267) polymorphism and breast cancer susceptibility: a meta-analysis involving 117,355 subjects.
    Zhang Y; Zeng X; Lu H; Ji H; Zhao E; Li Y
    Oncotarget; 2016 Oct; 7(42):68002-68011. PubMed ID: 27634905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between FGFR2 (rs2981582, rs2420946 and rs2981578) polymorphism and breast cancer susceptibility: a meta-analysis.
    Zhang Y; Zeng X; Liu P; Hong R; Lu H; Ji H; Lu L; Li Y
    Oncotarget; 2017 Jan; 8(2):3454-3470. PubMed ID: 27966449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Meta-Analysis of the Association between ESR1 Genetic Variants and the Risk of Breast Cancer.
    Li T; Zhao J; Yang J; Ma X; Dai Q; Huang H; Wang L; Liu P
    PLoS One; 2016; 11(4):e0153314. PubMed ID: 27070141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative assessment of common genetic variants on chromosome 5p12 and hormone receptor status with breast cancer risk.
    Yu Y; Chen Z; Wang H; Zhang Y
    PLoS One; 2013; 8(8):e72154. PubMed ID: 23977236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).
    Thomas G; Jacobs KB; Kraft P; Yeager M; Wacholder S; Cox DG; Hankinson SE; Hutchinson A; Wang Z; Yu K; Chatterjee N; Garcia-Closas M; Gonzalez-Bosquet J; Prokunina-Olsson L; Orr N; Willett WC; Colditz GA; Ziegler RG; Berg CD; Buys SS; McCarty CA; Feigelson HS; Calle EE; Thun MJ; Diver R; Prentice R; Jackson R; Kooperberg C; Chlebowski R; Lissowska J; Peplonska B; Brinton LA; Sigurdson A; Doody M; Bhatti P; Alexander BH; Buring J; Lee IM; Vatten LJ; Hveem K; Kumle M; Hayes RB; Tucker M; Gerhard DS; Fraumeni JF; Hoover RN; Chanock SJ; Hunter DJ
    Nat Genet; 2009 May; 41(5):579-84. PubMed ID: 19330030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a LSP1 gene rs3817198T>C polymorphism with breast cancer risk: evidence from 33,920 cases and 35,671 controls.
    Chen MB; Li C; Shen WX; Guo YJ; Shen W; Lu PH
    Mol Biol Rep; 2011 Oct; 38(7):4687-95. PubMed ID: 21127985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TOX high mobility group box family member 3 rs3803662 and breast cancer risk: A meta-analysis.
    Li L; Guo G; Wang F; Lv P; Zhu M; Gu Y; Han M; Pei X
    J Cancer Res Ther; 2018; 14(Supplement):S208-S212. PubMed ID: 29578175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11q13 is a susceptibility locus for hormone receptor positive breast cancer.
    Lambrechts D; Truong T; Justenhoven C; Humphreys MK; Wang J; Hopper JL; Dite GS; Apicella C; Southey MC; Schmidt MK; Broeks A; Cornelissen S; van Hien R; Sawyer E; Tomlinson I; Kerin M; Miller N; Milne RL; Zamora MP; Pérez JI; Benítez J; Hamann U; Ko YD; Brüning T; ; Chang-Claude J; Eilber U; Hein R; Nickels S; Flesch-Janys D; Wang-Gohrke S; John EM; Miron A; Winqvist R; Pylkäs K; Jukkola-Vuorinen A; Grip M; Chenevix-Trench G; Beesley J; Chen X; ; ; Menegaux F; Cordina-Duverger E; Shen CY; Yu JC; Wu PE; Hou MF; Andrulis IL; Selander T; Glendon G; Mulligan AM; Anton-Culver H; Ziogas A; Muir KR; Lophatananon A; Rattanamongkongul S; Puttawibul P; Jones M; Orr N; Ashworth A; Swerdlow A; Severi G; Baglietto L; Giles G; Southey M; Marmé F; Schneeweiss A; Sohn C; Burwinkel B; Yesilyurt BT; Neven P; Paridaens R; Wildiers H; Brenner H; Müller H; Arndt V; Stegmaier C; Meindl A; Schott S; Bartram CR; Schmutzler RK; Cox A; Brock IW; Elliott G; Cross SS; Fasching PA; Schulz-Wendtland R; Ekici AB; Beckmann MW; Fletcher O; Johnson N; Silva Idos S; Peto J; Nevanlinna H; Muranen TA; Aittomäki K; Blomqvist C; Dörk T; Schürmann P; Bremer M; Hillemanns P; Bogdanova NV; Antonenkova NN; Rogov YI; Karstens JH; Khusnutdinova E; Bermisheva M; Prokofieva D; Gancev S; Jakubowska A; Lubinski J; Jaworska K; Durda K; Nordestgaard BG; Bojesen SE; Lanng C; Mannermaa A; Kataja V; Kosma VM; Hartikainen JM; Radice P; Peterlongo P; Manoukian S; Bernard L; Couch FJ; Olson JE; Wang X; Fredericksen Z; Alnaes GG; Kristensen V; Børresen-Dale AL; Devilee P; Tollenaar RA; Seynaeve CM; Hooning MJ; García-Closas M; Chanock SJ; Lissowska J; Sherman ME; Hall P; Liu J; Czene K; Kang D; Yoo KY; Noh DY; Lindblom A; Margolin S; Dunning AM; Pharoah PD; Easton DF; Guénel P; Brauch H
    Hum Mutat; 2012 Jul; 33(7):1123-32. PubMed ID: 22461340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer susceptibility risk associations and heterogeneity by E-cadherin tumor tissue expression.
    Horne HN; Sherman ME; Garcia-Closas M; Pharoah PD; Blows FM; Yang XR; Hewitt SM; Conway CM; Lissowska J; Brinton LA; Prokunina-Olsson L; Dawson SJ; Caldas C; Easton DF; Chanock SJ; Figueroa JD
    Breast Cancer Res Treat; 2014 Jan; 143(1):181-7. PubMed ID: 24292867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.